This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Serous ovarian tumours

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

These account for about 20-50% of ovarian tumours. Histologically, papilliferous patterns are common. They are bilateral in 30% of cases. Commonly occur in women 30-40 years of age.

Benign serous cystadenomas:

  • 60% of serous tumours
  • 25% of all benign ovarian tumours
  • 100% 10 year survival

Borderline serous tumours:

  • 10% of serous tumours
  • 75% 10 year survival

Malignant serous cystadenocarcinoma:

  • 30% of serous tumours
  • 40-50% of all malignant ovarian tumours - most common
  • bilateral in 65% of cases
  • 15% 10 year survival as often widely disseminated at time of diagnosis

Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.